FibroScan®
Congress | 13.06.2026
Blog et actualités
topic :
category :
statut :
Communiqué de presse | 13.06.2026
Echosens Appoints Romain Baujard as Group Chief Executive Officer
Livre blanc | 13.06.2026
New White Paper – Vibration-Controlled Transient Elastography Explained
Article | 13.06.2026
Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)
Article | 13.06.2026
A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH
Communiqué de presse | 13.06.2026
Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH
Communiqué de presse | 13.06.2026
Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics
Communiqué de presse | 13.06.2026
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
Article | 13.06.2026
A call for doubling the diagnostic rate of at-risk MASH
Congress | 13.06.2026
Echosens is at EASL
Webinar | 13.06.2026
Prise en charge de l’hypertension portale à l’aide des tests non-invasifs
Article | 14.03.2026
New publication on our new technology Guided VCTE™
Webinar | 13.06.2026
Tests non-invasifs de fibrose : de nouveaux alliés pour les médecins addictologues
Communiqué de presse | 13.06.2026
Echosens lance sa plateforme de gestion de la santé du foie LHM à l’échelle mondiale, rationalisant ainsi les soins hépatiques
Communiqué de presse | 13.06.2026